LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 68.37 | 27.76 | 2313 | 6879 | 0.3362 | 0.7439 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 68.37 | 27.76 | 9066 | 6879 | 1.3179 | 1.0706 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.08 | 27.76 | 1017 | 6849 | 0.1485 | 0.5732 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.08 | 27.76 | 9859 | 6849 | 1.4393 | 1.0938 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.08 | 27.76 | 2209 | 6849 | 0.3225 | 0.7345 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 70.08 | 27.76 | 9312 | 6849 | 1.3595 | 1.0788 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 71.78 | 27.76 | 1029 | 6893 | 0.1493 | 0.5747 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 71.78 | 27.76 | 10101 | 6893 | 1.4654 | 1.0984 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 71.78 | 27.76 | 2168 | 6893 | 0.3145 | 0.7294 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 71.78 | 27.76 | 9508 | 6893 | 1.3793 | 1.0825 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 73.48 | 27.76 | 1082 | 6957 | 0.1555 | 0.5835 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 73.48 | 27.76 | 10337 | 6957 | 1.4857 | 1.1019 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 73.48 | 27.76 | 2250 | 6957 | 0.3234 | 0.7358 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 73.48 | 27.76 | 9796 | 6957 | 1.4079 | 1.0877 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.19 | 27.76 | 1033 | 7015 | 0.1473 | 0.5732 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.19 | 27.76 | 10583 | 7015 | 1.5086 | 1.1057 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.19 | 27.76 | 2351 | 7015 | 0.3351 | 0.7440 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 75.19 | 27.76 | 9933 | 7015 | 1.4159 | 1.0891 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.89 | 27.76 | 927 | 7025 | 0.1320 | 0.5519 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.89 | 27.76 | 10726 | 7025 | 1.5268 | 1.1089 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.89 | 27.76 | 2226 | 7025 | 0.3169 | 0.7318 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 76.89 | 27.76 | 10164 | 7025 | 1.4468 | 1.0947 | MN20160318_Q01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.60 | 27.76 | 877 | 7045 | 0.1245 | 0.5408 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.60 | 27.76 | 10953 | 7045 | 1.5545 | 1.1136 | MN20160318_Q01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 78.60 | 27.76 | 2261 | 7045 | 0.3209 | 0.7347 | MN20160318_Q01 | M15 |